Results 121 to 130 of about 491,590 (366)

Effectiveness and Safety of Reduced‐Dose Prasugrel in an East Asian Population: PRASFIT‐ACS Emulation Using National Health Insurance Claims Data

Clinical Pharmacology &Therapeutics, EarlyView.
Prasugrel is recommended for acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). However, East Asians exhibit a stronger antiplatelet response, raising concerns about bleeding risks with standard dosing. This retrospective cohort study evaluated the real‐world effectiveness and safety of reduced‐dose prasugrel in
Li‐Wen Huang, Yee‐Jen Wu, Fang‐Ju Lin, Chien‐Chih Wu, Hsin‐Yi Huang, Chi‐Chuan Wang, Xiaojuan Li   +6 more
wiley   +1 more source

Giant-cell Arteritis with Aneurysms [PDF]

, 1955
R. J. Harrison, C. V. Harrison, H. Kopelman   +2 more
openalex   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Comorbidity trajectories before and after the diagnosis of heart failure: A UK Biobank cohort study

European Journal of Heart Failure, EarlyView.
Time of diagnosis of comorbidities in relation to heart failure. COPD, chronic obstructive pulmonary disease; MI, myocardial infarction. Abstract Aims Heart failure (HF) is frequently associated with multiple comorbidities. We aimed to define their trajectory of accrual to identify opportunities for disease prevention. Methods and results We identified
Hugo MacGowan, Oliver I. Brown, Michael Drozd, Andrew M.N. Walker, Marilena Giannoudi, Sam Straw, Maria F. Paton, John Gierula, Melanie McGinlay, Kathryn J. Griffin, Klaus K. Witte, Mark T. Kearney, Richard M. Cubbon   +12 more
wiley   +1 more source

Tratamiento endovascular del trauma vascular periférico Endovascular treatment of peripheral vascular trauma

Revista Colombiana de Cirugía, 2012
El trauma vascular representa un problema de salud pública a nivel nacional e internacional. La epidemia de violencia con mayor uso de armas de alta y baja velocidad en los conflictos militares y a nivel civil urbano, las velocidades más altas en las ...
César Eduardo Jiménez, Diego Peña
doaj  

Cystic Medial Necrosis as a Cause of Localized Aortic Aneurysms Amenable to Surgical Treatment

, 1956
Henry T. Bahnson, Arthur R. Nelson
openalex   +2 more sources

Congenital Aneurysm of the Coronary Artery [PDF]

, 1959
M Grob, E Kolb
openalex   +1 more source

Aneurysms [PDF]

Postgraduate Medical Journal, 1971
openaire   +2 more sources

When Is a Coronary Artery Aneurysm Not an Aneurysm? [PDF]

The Annals of Thoracic Surgery, 2016
Maryam Alkuwari, Ali Kindawi, Willington Francis, Cornelia S Carr   +3 more
openaire   +3 more sources

Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death across cardio‐kidney‐metabolic diseases: A meta‐analysis of randomized clinical trials

European Journal of Heart Failure, EarlyView.
Abstract Aims Sudden cardiac death (SCD) is a prevalent cause of mortality among patients with cardio‐kidney‐metabolic (CKM) diseases. Mineralocorticoid receptor antagonists (MRAs) reduce the risk of SCD in patients with left ventricular dysfunction, but it is unclear if similar effects are expected across different CKM risk populations irrespective of
Pedro Marques, Faiez Zannad, João Pedro Ferreira   +2 more
wiley   +1 more source